Shared Decision Making for choosing renAl Replacement Therapy in chronic kidney disease patients
Not Applicable
Recruiting
- Conditions
- Diseases of the genitourinary system
- Registration Number
- KCT0006452
- Lead Sponsor
- Seoul National University Bundang Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1194
Inclusion Criteria
Chronic kidney disease grade 5 (defined as estimated glomerular filtration rate < 15 ml/dL/1.73m2 at least 2 times at intervals of 2 weeks or longer)
Age between 19 and 80 years
The nephrologists anticipate treating the patient with kidney replacement therapy within 12 months
Written informed consent
Exclusion Criteria
Contraindication to perform peritoneal dialysis due to abdominal surgery
Life expectancy is less than 6 months due to underlying diseases
Patients who have enrolled in other clinical trials within 3 months or plan to participate in other clinical trials during this clinical trial period
Patients judged by the investigator to be inappropriate for participation in this clinical trial.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method hemodialysis vs. non hemodlalysis
- Secondary Outcome Measures
Name Time Method cost effectiveness analysis;compliance ;satisfaction;To compare the rate of unplanned dialysis among the groups